The DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease
Open accessAbstract
Alzheimer’s disease (AD) is an aging-related neurological disorder characterized by synaptic loss and dementia. Wnt/β-catenin signaling is an essential signal transduction pathway that regulates numerous cellular processes including cell survival. In brain, Wnt/β-catenin signaling is not only crucial for neuronal survival and neurogenesis, but it plays important roles in regulating synaptic plasticity and blood-brain barrier integrity and function. Moreover, activation of Wnt/β-catenin signaling inhibits amyloid-β production and tau protein hyperphosphorylation in the brain. Critically, Wnt/β-catenin signaling is greatly suppressed in AD brain via multiple pathogenic mechanisms. As such, restoring Wnt/β-catenin signaling represents a unique opportunity for the rational design of novel AD therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“restoring Wnt/β-catenin signaling, which is greatly suppressed in AD brains, is a promising therapeutic strategy”
From CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease (2026) · cites this paper as [14]
The cited source says what the claim attributes to it.
In the citing paper
“Wnt/β-catenin signaling is not only crucial for neuronal survival and neurogenesis but also plays important roles in regulating synaptic plasticity and blood–brain barrier integrity and function [14].”
From CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease (2026) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Nusse, R., & Clevers, H. (2017) · Cell · doi:10.1016/j.cell.2017.05.016 · Cited by 4,342
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Cited by
Sorted by citations
Items 101–200 of 287
Jie, X., Ran, L., Zeng, X., He, W., Xu, Y., Cao, K., Dong, Y., Qi, X., Yu, W., Xiao, Y. C., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17006 · Cited by 18
Mikkelsen, A. C. D., Kjærgaard, K., Mookerjee, R. P., Vilstrup, H., Wegener, G., Bay-Richter, C., & Thomsen, K. L. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03551-x · Cited by 18
Cadherins and the pathogenesis of epilepsy
Yang, C., Shi, Y., Li, X., Guan, L., Li, H., & Lin, J. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3699 · Cited by 17
Targets and mechanisms of Alpinia oxyphylla Miquel fruits in treating neurodegenerative dementia
Zeng, P. H., Liu, Y.-C., Wang, X., Ye, C., Sun, Y., Su, H.-F., Qiu, S.-W., Li, Y., Wang, Y., Wang, Y., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1013891 · Cited by 17
Self-citationPrimary Cilia Structure Is Prolonged in Enteric Neurons of 5xFAD Alzheimer’s Disease Model Mice
Nguyen, V. T. T., Brücker, L., Volz, A.-K., Baumgärtner, J. C., dos Santos Guilherme, M., Valeri, F., May-Simera, H., & Endres, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413564 · Cited by 16
Bridging pathway dysfunction and therapy: novel compounds for neuroprotection
Patel, S., Prajapati, C., Nand, S., & Singh, S. K. (2026) · 3 Biotech · doi:10.1007/s13205-026-04697-z · Cited by 16
Liu, M., Guo, S., Huang, D., Hu, D., Wu, Y., Zhou, W., & Song, W. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215508 · Cited by 17
Tao, X., Jiang, Y., Zheng, X., Ji, X., & Peng, F. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12619 · Cited by 16
Lee, C.-Y., Riffle, D., Xiong, Y., Momtaz, N., Lei, Y., Pariser, J. M., Sikdar, D., Hwang, A., Duan, Z., & Zhang, J. (2024) · BMC Neuroscience · doi:10.1186/s12868-024-00867-y · Cited by 17
Potashkin, J. A., Bottero, V., Santiago, J. A., & Quinn, J. P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113787 · Cited by 17
Luo, X., Li, L., Zheng, W., Gu, L., Zhang, X., Li, Y., Xie, Z., & Cheng, Y. Z. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.06.003 · Cited by 16
Self-citationDrosophila melanogaster as a Model Organism to Study Lithium and Boron Bioactivity
Jans, K., Lüersen, K., & Rimbach, G. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111710 · Cited by 19
Khayachi, A., Schorova, L., Alda, M., Rouleau, G. A., & Milnerwood, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.002 · Cited by 15
Meng, T., Chen, Y., Wang, P., Yang, L., & Li, C. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00523-5 · Cited by 15
Yoon, M., Kim, H., Shin, H., Lee, H., Kang, M., Park, S., Han, G., Kim, Y. S., & Choi, K. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106836 · Cited by 15
Boopathi, S., Priya, P. S., Haridevamuthu, B., Nayak, S. P. R. R., Chandrasekar, M., Arockiaraj, J., & Jia, A. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106856 · Cited by 17
Association Between Wnt Target Genes and Cortical Volumes in Alzheimer’s Disease
Dong, L., Hou, B., Liu, C., Mao, C., Huang, X., Li, S., Chu, S., Peng, B., Cui, L., Feng, F., et al. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02122-1 · Cited by 15
Huang, L., Zhang, Y.-D., Chen, J., Fan, H., Wang, W., Wang, B., Ma, J., Li, P.-P., Pu, H.-W., Guo, X.-Y., et al. (2024) · Neural Regeneration Research · doi:10.4103/1673-5374.392889 · Cited by 16
Priya, Yadav, N., Anand, S., Banerjee, J., Tripathi, M., Chandra, P. S., & Dixit, A. B. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109942 · Cited by 15
Unlocking hope: GSK-3 inhibitors and Wnt pathway activation in Alzheimer’s therapy
Varshini, M. S., Reddy, R. A., & Krishnamurthy, P. T. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2365263 · Cited by 15
Wang, J., Zhuang, L., Ding, Y., Wang, Z., Xiao, W., & Zhu, J. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113807 · Cited by 15
Monteagudo, S., Cornelis, F. M. F., Wang, X., Roover, A. D., Peeters, T., Quintiens, J., Sermon, A., de Almeida, R. C., Meulenbelt, I., & Lories, R. J. U. (2022) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2022.02.615 · Cited by 15
Flores, A., Moyano, P. M., Solà, E., García, J. M., García, J., Anadón, M. J., Frejo, M. T., Naval, M. V., Fernández, M. D. L. C., & del Pino, J. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113500 · Cited by 15
The several ways to authentically cure Alzheimer’s dementia
Fessel, J. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102093 · Cited by 15
Li, J., Wang, P., Hou, M., & Zhu, B. T. (2023) · MedComm · doi:10.1002/mco2.301 · Cited by 14
DVL/GSK3/ISL1 pathway signaling: unraveling the mechanism of SIRT3 in neurogenesis and AD therapy
Dai, N., Su, X., Li, A., Li, J., Jiang, D., & Wang, Y. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03925-8 · Cited by 14
Wu, W., Wei, Z., Wu, Z., Chen, J., Liu, J. T., Chen, M., Yuan, J., Zheng, Z., Zhao, Z., Lin, Q., et al. (2024) · Cell Biology and Toxicology · doi:10.1007/s10565-024-09957-3 · Cited by 15
Drugs repurposing in the experimental models of Alzheimer’s disease
Joodi, S. A., Ibrahim, W. W., & Khattab, M. M. (2025) · Inflammopharmacology · doi:10.1007/s10787-024-01608-7 · Cited by 14
Zhao, Y., Yu, J., Ping, F., Xu, L., Li, W., Zhang, H., & Li, Y. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11366 · Cited by 15
Self-citationAlzheimer’s Disease and Impaired Bone Microarchitecture, Regeneration and Potential Genetic Links
Zhang, M., Hu, S., & Sun, X. (2023) · Life · doi:10.3390/life13020373 · Cited by 15
Sayed, N. S. E., Abidar, S., Nhiri, M., Hriţcu, L., & Ibrahim, W. W. (2023) · Phytotherapy Research · doi:10.1002/ptr.7766 · Cited by 18
Identification of Alzheimer’s Disease Molecular Subtypes Based on Parallel Large-Scale Sequencing
Ma, M., Liao, Y., Huang, X., Zou, C., Chen, L., Liang, L., Meng, Y., Wu, Y., & Zou, D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.770136 · Cited by 14
MicroRNA Dysregulation in the Hippocampus of Rats with Noise‐Induced Hearing Loss
Ha, S., Kim, K. W., Lee, S. M., Lee, C. H., & Kim, S. Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/1377195 · Cited by 13
Role of Neddylation in Neurodegenerative Diseases
Govindarajulu, M., Ramesh, S., Shankar, T., Kora, M. K., Moore, T., & Dhanasekaran, M. (2022) · NeuroSci · doi:10.3390/neurosci3040038 · Cited by 13
Suresh, S., & Vellapandian, C. (2024) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2024.116953 · Cited by 13
Jo, D., Choi, S. Y., Ahn, S. Y., & Song, J. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117846 · Cited by 14
Li, Y., Xu, X., Xu, Y., Li, C., Xie, F., Guo, M., Liu, Z., & Liu, X. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113673 · Cited by 13
Self-citationChoi, J.-W., Kang, S. J., Choi, J. I., Kwack, K., & Kim, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052900 · Cited by 13
Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer’s Disease
Gherardelli, C., Cisternas, P., Vera-Salazar, R. F., Méndez‐Orellana, C., & Inestrosa, N. C. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215273 · Cited by 13
Zhang, W., Zhang, Y., Hu, N., & Wang, A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.990779 · Cited by 12
Brain–Bone Axis in Physiological and Pathological Conditions
Massaccesi, L., Romanelli, M. M. C., & Galliera, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199822 · Cited by 13
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
Loeffler, D. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240212 · Cited by 12
Neurotoxicity of the antineoplastic drugs: “Doxorubicin” as an example
Fouad, G. I., & Rizk, M. Z. (2024) · Journal of Molecular Histology · doi:10.1007/s10735-024-10247-9 · Cited by 12
Wnt/β-catenin Signaling in Central Nervous System Regeneration
Nazli, D., Bora, U., & Özhan, G. (2024) · Advances in experimental medicine and biology · doi:10.1007/5584_2024_830 · Cited by 12
Polyphenols as Wnt/β‐catenin pathway modulators: A promising strategy in clinical neurodegeneration
Utpal, B. K., Roy, S. C., Zehravi, M., Sweilam, S. H., Raja, A. D., Haque, M. A., Nayak, C., Balakrishnan, S., Singh, L. P., Panigrahi, S., et al. (2025) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12525 · Cited by 12
Cellular and Molecular Mechanisms of Spinal Cord Vascularization
Vieira, J. R., Shah, B., & de Almodóvar, C. R. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.599897 · Cited by 12
Li, B., Zhou, M., Peng, J. Y., Yang, Q., Chu, J., Li, R., & Jiang, Y. (2021) · Immunological Investigations · doi:10.1080/08820139.2021.1970180 · Cited by 12
Devo-Aging: Intersections Between Development and Aging
Silva-García, C. G. (2023) · GeroScience · doi:10.1007/s11357-023-00809-2 · Cited by 14
Impact of GSK-3β and CK-1δ on Wnt signaling pathway in alzheimer disease: A dual target approach
Sharma, V., Sharma, P. C., Reang, J., Yadav, V., Tonk, R. K., Majeed, J., & Sharma, K. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107378 · Cited by 11
Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12
Aging disrupts hepatocyte zonation homeostasis in mice and humans
Sinha, S., Ali, Q., Zhang, T., T-Nguyen, D. H., Hanna, S., Sethiadi, J., Hissong, E. M., & Schwartz, R. E. (2025) · Hepatology · doi:10.1097/hep.0000000000001451 · Cited by 12
Computational Strategies to Identify New Drug Candidates against Neuroinflammation
Pavan, M., Bassani, D., Bolcato, G., Bissaro, M., Sturlese, M., & Moro, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220208095122 · Cited by 11
So, S. W., Nixon, J. P., Bernlohr, D., & Butterick, T. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043381 · Cited by 11
Li, H., Li, J., Zhang, Y., Zhao, C., Ge, J., Sun, Y., Fu, H., & Li, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1401979 · Cited by 12
Self-citationNradd Acts as a Negative Feedback Regulator of Wnt/β-Catenin Signaling and Promotes Apoptosis
Özalp, Ö., Çark, Ö., Azbazdar, Y., Haykir, B., Cucun, G., Küçükaylak, I., Yeşilyurt, G. A., Sezgin, E., & Özhan, G. (2021) · Biomolecules · doi:10.3390/biom11010100 · Cited by 12
Vastrad, B. M., & Vastrad, C. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.06.442918 · Cited by 11
Ramasubbu, K., Venkatraman, G., Ramanathan, G., Dhanasekar, S., & Rajeswari, V. D. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122640 · Cited by 10
Fang, K. (2024) · Ibrain · doi:10.1002/ibra.12185 · Cited by 10
Li, Y., Yang, C., Liu, X., Shu, J., Zhao, N., Sun, Z., Tabish, M. S., Hong, Y., Liu, E., Wei, N., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.009 · Cited by 10
Self-citationHao, Z., Liu, K., Zhou, L., & Chen, P. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1193031 · Cited by 10
Investigation of Potential Drug Targets for Cholesterol Regulation to Treat Alzheimer’s Disease
Passero, M., Zhai, T., & Huang, Z. J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20136217 · Cited by 10
Chen, Z. S., Ou, M., Taylor, S., Dafinca, R., Peng, S. I., Talbot, K., & Chan, H. Y. E. (2023) · Nature Communications · doi:10.1038/s41467-023-44215-w · Cited by 10
Wnt Signaling Rescues Amyloid Beta-Induced Gut Stem Cell Loss
Kaur, P., Chua, E. H. Z., Lim, W. K., Liu, J., Harmston, N., & Tolwinski, N. S. (2022) · Cells · doi:10.3390/cells11020281 · Cited by 10
Neurogenesis Is Increased in Human Neural Stem Cells by Aβ40 Peptide
Bernabeu-Zornoza, A., Coronel, R., Palmer, C., Martín, A., López-Alonso, V., & Liste, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105820 · Cited by 11
Poddar, N. K., Agarwal, D., Agrawal, Y., Wijayasinghe, Y. S., Mukherjee, A., & Khan, S. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166524 · Cited by 10
El-Sayed, N. S., Khalil, N. A., Saleh, S. R., Aly, R. G. M., & Basta, M. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02232-4 · Cited by 9
Sharma, H. S., Lafuente, J. V., Feng, L., Muresanu, D. F., Menon, P. K., Nozari, A., Sahib, S., Tian, Z. R., Buzoianu, A. D., Sjöquist, P.-O. B., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.06.008 · Cited by 9
Ghasemi, A., Qaffaripour, Z., Tourani, M., Saleki, K., Rahmani-Kukia, N., Khatami, S. H., & Taheri‐Anganeh, M. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114434 · Cited by 9
Manandhar, S., Priya, K., Mehta, C. H., Nayak, U. Y., Kabekkodu, S. P., & Pai, K. S. R. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1930583 · Cited by 9
Raafat, R. S., Habib, M. Z., AbdElfattah, A. A., Olama, N. K., Abdelraouf, S. M., Hendawy, N., Kamal, K. A., Nawishy, S., & Aboul‐Fotouh, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110945 · Cited by 8
Shrestha, P., Basida, B., Elam, R. E., Hajj, J. E., Le, B. K., Fink, H. A., Bethel, M., Tharrington, S. G., & Carbone, L. D. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-025-00924-3 · Cited by 8
Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy – a review
Markowicz-Piasecka, M., Miłkowska, Z., Adla, S. K., Huttunen, K. M., & Pietrzak, B. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103658 · Cited by 9
Liu, Y., Zhang, J., Tang, L., Yang, J., Hao, L., Lou, F., & Su, J. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04174-1 · Cited by 8
Hooshmandi, E., Akbari, S., Pandamooz, S., Ghobadi, M., Ghasemi, R., Maghsoudi, N., Nand, S., Borhani‐Haghighi, A., Salehi, M. S., Azarpira, N., et al. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114655 · Cited by 8
Abbatecola, A. M., Arosio, B., Cerasuolo, M., Auriemma, M. C., Meo, I. D., Langiano, E., & Rizzo, M. R. (2024) · Journal of Gerontology and Geriatrics · doi:10.36150/2499-6564-n691 · Cited by 8
Unearthing nature's remedy: An exploration into Lycopodium's medicinal and therapeutic potential
Niinuma, S. A., Khudair, A. D., Habib, H., Khudair, A. D., Mackenzie, G., Atkin, S. L., & Butler, A. E. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102197 · Cited by 8
Kar, P., Millo, T., Saha, S., Mahtab, S., Agarwal, S., & Goswami, R. (2021) · Endocrinology · doi:10.1210/endocr/bqab024 · Cited by 8
Zhao, X., Qiao, D., Guan, D., Wang, K., & Cui, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9399658 · Cited by 8
RetractedZhuo, R., Song, Z., Wang, Y., Zhu, M., Liu, F., Lin, P., Rao, R., Zhou, Y., Zhao, Y., Fan, Z., et al. (2023) · Phytotherapy Research · doi:10.1002/ptr.7970 · Cited by 8
Self-citationLooking at Alzheimer’s Disease Pathogenesis from the Nuclear Side
D’Andrea, L., Stringhi, R., Luca, M. D., & Marcello, E. E. (2021) · Biomolecules · doi:10.3390/biom11091261 · Cited by 8
Patil, M., Gamit, N., Dharmarajan, A., Sethi, G., & Warrier, S. R. (2023) · Bioengineering · doi:10.3390/bioengineering10020192 · Cited by 9
Patel, D., Zhang, X., Farrell, J. J., Lunetta, K. L., & Farrer, L. A. (2021) · Genes · doi:10.3390/genes12030419 · Cited by 8
Garg, A., Saroj, J., Tiwari, S., Das, U., Shukla, N., Ghosh, J. K., & Bandyopadhyay, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1510337 · Cited by 7
SHARMA, A. K., Mannan, A., & Singh, T. G. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01642-6 · Cited by 7
Vashisht, K., Kumar, H., Ankalgi, A. D., Ashawat, M. S., Rimpi, Kushawaha, S. K., & Baldi, A. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01869-w · Cited by 7
Oudaha, K. H., Najm, M. A. A., Ramsis, T. M., Ebrahim, M. A., Gohar, N. A., Abu‐Elfotuh, K., Mohamed, E. K., Hamdan, A. M., Hamdan, A. M., Almotairi, R., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18081214 · Cited by 7
Rahimmi, A., Fathi, F., Nikkhoo, B., Soleimani, F., & Khademerfan, M. (2022) · PubMed Central · doi:10.22038/ijbms.2022.64345.14165 · Cited by 7
Li, J., Lyu, X., Wang, P., & Zhu, B. T. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105827 · Cited by 7
Importance of GWAS in finding un-targeted genetic association of sporadic Alzheimer’s disease
Bagaria, J., Nho, K. T., & An, S. S. A. (2021) · Molecular & Cellular Toxicology · doi:10.1007/s13273-021-00130-z · Cited by 8
Prajapat, M., Sarma, P., Kaur, G., Choudhary, G. P., Jain, S., Kamal, R., Bains, O., Sangwan, N., Prakash, A., & Medhi, B. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251362787 · Cited by 6
Protocadherin gamma C3: a new player in regulating vascular barrier function
Burek, M., Kaupp, V., Blecharz-Lang, K. G., Dilling, C., & Meybohm, P. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.343896 · Cited by 7
Iemmolo, M., Bivona, G., Piccoli, T., Nicosia, A., Schiera, G., Liegro, C. M. D., Pietra, F. D., & Ghersi, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052510 · Cited by 6
Huang, J., Pang, X., Yang, H., Gao, C., Wang, D., Sun, Y., Taishi, Y., & Pang, C.-Y. (2024) · Current Alzheimer Research · doi:10.2174/0115672050333760241010061547 · Cited by 6
Wang, L., Wang, X., Hou, L., Liu, Y., Liu, J., Zhang, D., Yao, S., & Zheng, D. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251315848 · Cited by 6
Tosun, U. U., Aydın, S. T., Tiryaki, A., Baykara, D., Yakut, A., Rayaman, E., Taşkın, T., Doğan, C. E., Gündüz, O., & Ağralı, Ö. B. (2025) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-025-04828-8 · Cited by 6
Shalaby, H. N., Zaki, H. F., Ain-Shoka, A. A., & Mohammed, R. A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02977-2 · Cited by 6
Fan, F., & Chen, C. (2024) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2024051776 · Cited by 6
Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Shekho, D., Mishra, R., Kamal, R., Bhatia, R., & Awasthi, A. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02923-6 · Cited by 6
Li, N., Chu, J., Hu, K., Zhang, H., Li, N., Hu, K., Hu, K., & Zhang, H. (2023) · Journal of Biosciences · doi:10.1007/s12038-023-00340-8 · Cited by 6
Krivonosov, M., Nazarenko, T., Bacalini, M. G., Vedunova, M., Franceschi, C., Zaikin, A. A., & Ivanchenko, M. (2022) · UCL Discovery (University College London) · Cited by 6
Metadata
- Authors
- Jia, L., Piña-Crespo, J., & Li, Y.
- Affiliations
- Mayo Clinic (US)
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Corresponding author
- Li, Yonghe
- Venue
- Molecular Brain
- Published
- 2019-12
- Volume
- 12
- Issue
- 1
- Pages
- 104-104
- ISSN
- 1756-6606 (ISSN-L)
- PMC
- PMC6894260
- OpenAlex
- W2992486783
- Cited by
- 288
- References
- 187
- Citations by year
- 2026: 31 · 2025: 42 · 2024: 48 · 2023: 48 · 2022: 57 · 2021: 45 · 2020: 16
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecular Brain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- The Ed and Ethel Moore Alzheimer’s Disease Research Program Pilot Grant from the Florida Department of Health (9AZ09)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, Wnt/β-catenin signaling, therapeutic target, synaptic plasticity, blood-brain barrier, amyloid-beta production, tau hyperphosphorylation, neuronal survival, neurogenesis, synaptic loss
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Neuronal Plasticity, Neurogenesis, Molecular Targeted Therapy, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review